Abstract A methoxylated flavanone derivative, 2 0 ,3 0 ,4 0 -trimethoxy-5,6-naphthoflavanone (TMNF), was synthesized, and its anti-proliferative activity was evaluated. In HCT116 colon cancer cells, TMNF inhibited cellular proliferation and triggered cytotoxicity. A flow cytometry assay showed that TMNF caused cell cycle arrest at the G2/ M phase with a concomitant decrease in the population of G1 phase cells. Furthermore, TMNF caused accumulation of p53 and its downstream target, Bax, and stimulated cleavage of caspase-7 and poly(ADP-ribose) polymerase. These data suggest that methoxylated naphthoflavanone can be an attractive pharmacophore for further development of therapeutic adjuvants.
Introduction
Flavonoids are the most common polyphenolic compounds and are found in most higher plants. They exhibit a wide range of complex biological and pharmacological activities in the human body, including antioxidant, antiinflammatory, anti-microbial, and anti-tumor activities (Yao et al. 2004 ). Chemically, flavonoids possess a C6-C3-C6 carbon skeleton, consisting of two phenyl rings (A and B rings) and a heterocyclic ring (Fig. 1A) . Based on skeleton structure, flavonoids are classified into several subgroups, such as chalcones, flavones, flavonols, flavanones, anthocyanins, and isoflavonoids (Prasad et al. 2010) . Among flavanones, naringenin (4 0 ,5,7-trihydroxyflavanone), which is found in grape fruit, has an antiinflammatory effect (Hanakova et al. 2015) , and hesperetin (3 0 ,5,7-trihydroxy-4 0 -methoxyflavanone), found in citrus fruits, can act as a chemotherapeutic agent (Bodduluru et al. 2015) . Sakuranetin (4 0 -5-dihydroxy-7-methoxyflavanone), found in rice, is known to have antimicrobial activity (Ticha et al. 2015) . It has been reported that 6-naphthoflavone induces cytochrome P450-mediated liver metabolism (Nakai et al. 1992) , whereas methoxylated flavonoids show an increased intestinal absorption and hepatic metabolic stability (Wen and Walle 2006) . However, the antitumor activity of methoxylated naphthoflavanone remains unclear. The aim of the present study was to characterize the antiproliferative effect of a synthetic 2 0 ,3 0 ,4 0 -trimethoxy-5,6-naphthoflavanone (TMNF) for development of a potent chemotherapeutic agent. Here, we found that TMNF triggers apoptosis in HCT116 colon cancer cells, likely through accumulation of p53 and activation of caspasemediated pathways.
Materials and methods
Chemicals TMNF (Fig. 1A ) was synthesized as described previously (Hwang et al. 2012) . Other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Cells and cell culture

Flow cytometry for cell cycle analysis
Cellular DNA contents were analyzed by flow cytometry as previously described (Shin et al. 2012) . Briefly, HCT116 cells were treated with 20 lM TMNF for 12 and 24 h, fixed in 70 % (v/v) ethanol, washed twice in phosphatebuffered saline (PBS), and then stained with 50 lg/mL propidium iodide (PI) containing 0.1 % (v/v) Triton X-100, 0.1 mM EDTA, and 50 lg/mL RNase A. Fluorescence was measured with a NucleoCounter NC-3000 (ChemoMetec, Allerød, Denmark).
Analysis of apoptosis by Annexin V staining
HCT116 cells (1 9 10 6 cells/sample) were treated with 20 lM TMNF for 48 h. The cells were incubated with fluorescein isothiocyanate (FITC)-conjugated Annexin V according to the manufacturer's instructions (ChemoMetec). PI was used to counterstain dead cells. The number of FITC-and PI-positive cells was analyzed by flow cytometry using a NucleoCounter NC-3000 (ChemoMetec).
Immunoblot analysis
HCT116 cells were lysed, and immunoblotting was performed as described previously (Shin et al. 2013) . Antibodies specific to cyclin D1, cyclin B1, cleaved caspase-7, and poly(ADP-ribose) polymerase were obtained from Cell The data shown represent the mean ± SD of one experiment performed in triplicate. **P \ 0.01 Signaling Technology. Antibodies against Bax, p53, and GAPDH were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Signals were detected using an enhanced chemiluminescence detection system (Amersham Pharmacia Biotech, NJ, USA).
Statistical analysis
Each experiment was repeated at least three times. Data are presented as the mean ± SD. Statistical comparisons were performed using the Student's t test or two-factor ANOVA using InStat version 3.0 software (GraphPad Software Inc., La Jolla, CA, USA), as appropriate. A P value of \0.05 was considered statistically significant.
Results and discussion
We first assessed the anti-proliferative effect of TMNF toward HCT116 human colorectal cancer cells. HCT116 cells were treated with various concentrations of TMNF and cellular proliferation rate was measured using incorporation of the thymidine analogue BrdU into the newly synthesized DNA of proliferation cells. A dose-and time-dependent decrease in cellular proliferation was observed in cells treated with TMNF, compared with untreated control cells (Fig. 1B) . To determine whether TMNF displayed cytotoxicity, a metabolic viability assay was performed using a Cell Counting Kit. A significant concentration-dependent decrease in cell viability was observed in cells treated with TMNF for 48 h compared with untreated control cells (Fig. 1C) . The IC 50 value was approximately 20 lM.
To test whether TMNF alters cell cycle progression, we performed a flow cytometric analysis. Upon TMNF treatment, G1-phase cells decreased from 54.5 % in the control to 16.7 and 6.3 % at 12 h and 24 h, whereas G2/Mphase cells increased from 24.8 % in the control to 64.5 and 82.9 % at 12 h and 24 h, respectively ( Fig. 2A) . Cyclins are involved in the regulation of cell cycle progression by activating cyclin-dependent kinase (Cdk). It is well established that Cdk4/6 forms a complex with cyclin D (D1, D2, and D3) to regulate G1 phase progression, whereas Cdk1 forms a complex with cyclin B to control G2/M progression and mitosis (Nurse 1990) . The Cdk4/6 and Cdk1 enzyme activities depend on expression levels of cyclin D1 and cyclin B1, respectively. To test whether TMNF can alter the expression of cyclin D or cyclin B, HCT116 cells were treated with TMNF, and the steadystate levels of cyclin D1 and cyclin B1 were determined by immunoblotting. After 12 h of TMNF treatment, the amount of cyclin D1 protein had decreased, whereas cyclin B1 level had increased compared to untreated control cells (Fig. 2B) . These results suggest that TMNF causes inhibition of cell cycle progression through the dysregulation of cell cycle regulators.
We also observed that sub-G1 phase cells, a hallmark of apoptosis, accumulated (from 1.0 to 3.9 %) following 24 h of TMNF treatment ( Fig. 2A) , indicative of apoptosis. Phosphatidylserine (PS) is a membrane phospholipid located in the cytosolic leaflet of the cell membrane. During apoptosis, PS is translocated to the exoplasmic leaflet (Lum et al. 2005) , leading to sending of a phagocytic signal to the macrophages that engulf apoptotic cells (Fadok et al. 1992) . Thus, early apoptotic events can be characterized by surface exposure of PS. To address whether TMNF causes the induction of apoptosis, we determined whether PS could be detected on the outer membrane of cells using FITC-labeled Annexin-V (AV), Thus, total apoptotic and dead cells were increased from 15 to 56 % (bottom panels). These data suggest that TMNF triggers apoptosis in HCT116 cells. The human TP53 gene encodes tumor suppressor p53 protein, which plays a crucial role in the regulation of apoptosis via induction of pre-apoptotic Bax protein in response to DNA damage and cellular stress responses (Miyashita et al. 1994) . Caspases are cysteine-dependent aspartate-specific proteases, which play the central role in transduction of apoptotic signals (Danial and Korsmeyer 2004) . Caspases can be divided into two types: initiator caspases (caspase-2, -8, -9, and -10) and effector caspases (caspase-3 and -7). Activated initiator caspases cleave and activate effector caspases, which are involved in cleavage of multiple cellular protein substrates, resulting in triggering of apoptosis. It is well established that Bax accumulation causes the release of cytochrome c from mitochondria, leading to the activation of caspase-9 (Slee et al. 1999) . Upon TMNF treatment, protein levels of p53 and its downstream target, Bax, increased in a time-dependent manner (Fig. 3B) . Furthermore, we observed that both caspase-7 and its downstream substrate, poly(ADPribose) polymerase (PARP), were also cleaved upon TMNF treatment. These data raise the possibility that TMNF triggers sequential activation of the p53/Bax/caspase-9/caspase-7 cascade to induce the apoptotic cell death program.
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In summary, we synthesized and characterized a TMNF and showed that this flavanone derivative induces apoptosis in HCT116 human colon cancer cells. Our findings indicate that methoxylated naphthoflavanone is an attractive pharmacophore for further development of therapeutic adjuvants. agulant alpha (VAC alpha) to planar phospholipid bilayers. (0, 3, 6, 12 , and 24 h). Whole-cell lysates were prepared and subjected to immunoblotting using antibodies against p53, Bax, cleaved caspase-7, and PARP. GAPDH antibody was used as an internal control to show equal protein loading. Each blot represents at least three individual experiments
